CSF2 and melanoma: The enhancement of GM-CSF secretion from YDFR.CB3 cells by rhIL-1α or rhTNF-α treatment was inhibited by ~20 % when melanoma cells were treated with rhIL-1α or rhTNF-α mixed with microglia conditioned medium (Figure 2g,h).